Watchlist Price Alert

X4 Pharmaceuticals Inc. (XFOR)

NASDAQ: XFOR · Real-Time Price · USD

2.70

-0.12 (-4.26%)

At close: Jun 16, 2025, 3:59 PM

2.74

1.48%

Pre-market: Jun 17, 2025, 05:39 AM EDT

X4 Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	2.56M	n/a	n/a	n/a	3M	n/a	3.5M	n/a	n/a
Cost of Revenue	797K	2M	1.99M	1.89M	n/a	672K	103K	195K	300K
Gross Profit	1.76M	-2M	-1.99M	-1.89M	3M	-672K	3.4M	-195K	-300K
Operating Income	-36.4M	-107.52M	-87.57M	-85.11M	-59.87M	-51.7M	-45.88M	-36.13M	-24.35M
Interest Income	5.77M	4.58M	219K	10K	273K	1.2M	809K	214K	n/a
Pretax Income	-37.14M	-101.09M	-93.84M	-88.68M	-61.98M	-52.81M	-43.02M	-33.88M	-22.98M
Net Income	-37.45M	-101.17M	-93.87M	-88.7M	-62.13M	-56.6M	-43.02M	-33.88M	-22.98M
Selling & General & Admin	61.52M	35.51M	27.02M	24.7M	20.94M	17.64M	18.41M	8.01M	6.51M
Research & Development	81.64M	70.02M	61.06M	50.65M	41.93M	30.16M	30.98M	28.13M	17.83M
Other Expenses	-105M	n/a	-6.27M	-3.57M	-2.11M	-1.1M	-85K	-16K	104K
Operating Expenses	38.16M	107.52M	88.08M	75.35M	62.87M	47.8M	46.21M	32.27M	21.96M
Interest Expense	8.77M	5.78M	3.99M	3.64M	2.69M	2.15M	1.04M	2.08M	2.52M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	38.96M	107.52M	88.08M	75.35M	62.87M	47.8M	46.21M	32.27M	21.96M
Income Tax Expense	310K	78K	28K	17K	148K	3.8M	3.9M	1.87M	2.62M
Shares Outstanding (Basic)	201.06M	177.81M	61.85M	22.25M	20.08M	11.4M	420.8K	403.03K	4.08M
Shares Outstanding (Diluted)	201.06M	177.81M	63.53M	25.75M	20.08M	11.53M	459K	458K	4.77M
EPS (Basic)	-0.19	-0.57	-1.52	-3.99	-3.09	-4.63	-79.1	-54.57	-4.38
EPS (Diluted)	-0.19	-0.57	-1.52	-3.99	-3.09	-4.63	-79.1	-54.57	-4.38
EBITDA	-27.58M	-107.1M	-87.57M	-85.11M	-58.06M	-51.7M	-45.88M	-31.6M	-20.16M
EBIT	-28.37M	-107.52M	-89.85M	-85.04M	-59.3M	-50.66M	-32.56M	-31.8M	-20.46M
Depreciation & Amortization	796K	419K	1.99M	1.89M	1.23M	672K	103K	195K	300K